The global Oxcarbazepine Tablets market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Novartis (Trileptal)
Mylan
Sun Pharm
Supernus Pharmaceuticals (Oxtellar XR)
Stada Group
Apotex
Hikma Pharmaceuticals
Taro Pharmaceuticals
Jubilant Generics
Teva Pharmaceutical
Jamp Pharma
SihuanPharm
ANI Pharmaceuticals
Huikang Pharmaceutical
Neuraxpharm
Nobelpharma
Glenmark Pharmaceuticals
Humanwell Healthcare
Orion Corporation
Roxane Laboratories
Nexgen pharma
By Types:
Tablets (150mg)
Tablets (300mg)
Tablets (600mg)
By Applications:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Oxcarbazepine Tablets Market Size Analysis from 2022 to 2027
1.5.1 Global Oxcarbazepine Tablets Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Oxcarbazepine Tablets Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Oxcarbazepine Tablets Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Oxcarbazepine Tablets Industry Impact
Chapter 2 Global Oxcarbazepine Tablets Competition by Types, Applications, and Top Regions and Countries
2.1 Global Oxcarbazepine Tablets (Volume and Value) by Type
2.1.1 Global Oxcarbazepine Tablets Consumption and Market Share by Type (2016-2021)
2.1.2 Global Oxcarbazepine Tablets Revenue and Market Share by Type (2016-2021)
2.2 Global Oxcarbazepine Tablets (Volume and Value) by Application
2.2.1 Global Oxcarbazepine Tablets Consumption and Market Share by Application (2016-2021)
2.2.2 Global Oxcarbazepine Tablets Revenue and Market Share by Application (2016-2021)
2.3 Global Oxcarbazepine Tablets (Volume and Value) by Regions
2.3.1 Global Oxcarbazepine Tablets Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Oxcarbazepine Tablets Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Oxcarbazepine Tablets Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Oxcarbazepine Tablets Consumption by Regions (2016-2021)
4.2 North America Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
4.10 South America Oxcarbazepine Tablets Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Oxcarbazepine Tablets Market Analysis
5.1 North America Oxcarbazepine Tablets Consumption and Value Analysis
5.1.1 North America Oxcarbazepine Tablets Market Under COVID-19
5.2 North America Oxcarbazepine Tablets Consumption Volume by Types
5.3 North America Oxcarbazepine Tablets Consumption Structure by Application
5.4 North America Oxcarbazepine Tablets Consumption by Top Countries
5.4.1 United States Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
5.4.2 Canada Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
5.4.3 Mexico Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 6 East Asia Oxcarbazepine Tablets Market Analysis
6.1 East Asia Oxcarbazepine Tablets Consumption and Value Analysis
6.1.1 East Asia Oxcarbazepine Tablets Market Under COVID-19
6.2 East Asia Oxcarbazepine Tablets Consumption Volume by Types
6.3 East Asia Oxcarbazepine Tablets Consumption Structure by Application
6.4 East Asia Oxcarbazepine Tablets Consumption by Top Countries
6.4.1 China Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
6.4.2 Japan Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
6.4.3 South Korea Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 7 Europe Oxcarbazepine Tablets Market Analysis
7.1 Europe Oxcarbazepine Tablets Consumption and Value Analysis
7.1.1 Europe Oxcarbazepine Tablets Market Under COVID-19
7.2 Europe Oxcarbazepine Tablets Consumption Volume by Types
7.3 Europe Oxcarbazepine Tablets Consumption Structure by Application
7.4 Europe Oxcarbazepine Tablets Consumption by Top Countries
7.4.1 Germany Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.2 UK Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.3 France Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.4 Italy Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.5 Russia Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.6 Spain Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.7 Netherlands Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.8 Switzerland Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
7.4.9 Poland Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 8 South Asia Oxcarbazepine Tablets Market Analysis
8.1 South Asia Oxcarbazepine Tablets Consumption and Value Analysis
8.1.1 South Asia Oxcarbazepine Tablets Market Under COVID-19
8.2 South Asia Oxcarbazepine Tablets Consumption Volume by Types
8.3 South Asia Oxcarbazepine Tablets Consumption Structure by Application
8.4 South Asia Oxcarbazepine Tablets Consumption by Top Countries
8.4.1 India Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
8.4.2 Pakistan Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Oxcarbazepine Tablets Market Analysis
9.1 Southeast Asia Oxcarbazepine Tablets Consumption and Value Analysis
9.1.1 Southeast Asia Oxcarbazepine Tablets Market Under COVID-19
9.2 Southeast Asia Oxcarbazepine Tablets Consumption Volume by Types
9.3 Southeast Asia Oxcarbazepine Tablets Consumption Structure by Application
9.4 Southeast Asia Oxcarbazepine Tablets Consumption by Top Countries
9.4.1 Indonesia Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
9.4.2 Thailand Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
9.4.3 Singapore Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
9.4.4 Malaysia Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
9.4.5 Philippines Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
9.4.6 Vietnam Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
9.4.7 Myanmar Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 10 Middle East Oxcarbazepine Tablets Market Analysis
10.1 Middle East Oxcarbazepine Tablets Consumption and Value Analysis
10.1.1 Middle East Oxcarbazepine Tablets Market Under COVID-19
10.2 Middle East Oxcarbazepine Tablets Consumption Volume by Types
10.3 Middle East Oxcarbazepine Tablets Consumption Structure by Application
10.4 Middle East Oxcarbazepine Tablets Consumption by Top Countries
10.4.1 Turkey Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.3 Iran Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.5 Israel Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.6 Iraq Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.7 Qatar Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.8 Kuwait Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
10.4.9 Oman Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 11 Africa Oxcarbazepine Tablets Market Analysis
11.1 Africa Oxcarbazepine Tablets Consumption and Value Analysis
11.1.1 Africa Oxcarbazepine Tablets Market Under COVID-19
11.2 Africa Oxcarbazepine Tablets Consumption Volume by Types
11.3 Africa Oxcarbazepine Tablets Consumption Structure by Application
11.4 Africa Oxcarbazepine Tablets Consumption by Top Countries
11.4.1 Nigeria Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
11.4.2 South Africa Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
11.4.3 Egypt Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
11.4.4 Algeria Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
11.4.5 Morocco Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 12 Oceania Oxcarbazepine Tablets Market Analysis
12.1 Oceania Oxcarbazepine Tablets Consumption and Value Analysis
12.2 Oceania Oxcarbazepine Tablets Consumption Volume by Types
12.3 Oceania Oxcarbazepine Tablets Consumption Structure by Application
12.4 Oceania Oxcarbazepine Tablets Consumption by Top Countries
12.4.1 Australia Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
12.4.2 New Zealand Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 13 South America Oxcarbazepine Tablets Market Analysis
13.1 South America Oxcarbazepine Tablets Consumption and Value Analysis
13.1.1 South America Oxcarbazepine Tablets Market Under COVID-19
13.2 South America Oxcarbazepine Tablets Consumption Volume by Types
13.3 South America Oxcarbazepine Tablets Consumption Structure by Application
13.4 South America Oxcarbazepine Tablets Consumption Volume by Major Countries
13.4.1 Brazil Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.2 Argentina Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.3 Columbia Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.4 Chile Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.5 Venezuela Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.6 Peru Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
13.4.8 Ecuador Oxcarbazepine Tablets Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Oxcarbazepine Tablets Business
14.1 Novartis (Trileptal)
14.1.1 Novartis (Trileptal) Company Profile
14.1.2 Novartis (Trileptal) Oxcarbazepine Tablets Product Specification
14.1.3 Novartis (Trileptal) Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Mylan
14.2.1 Mylan Company Profile
14.2.2 Mylan Oxcarbazepine Tablets Product Specification
14.2.3 Mylan Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Sun Pharm
14.3.1 Sun Pharm Company Profile
14.3.2 Sun Pharm Oxcarbazepine Tablets Product Specification
14.3.3 Sun Pharm Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Supernus Pharmaceuticals (Oxtellar XR)
14.4.1 Supernus Pharmaceuticals (Oxtellar XR) Company Profile
14.4.2 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product Specification
14.4.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Stada Group
14.5.1 Stada Group Company Profile
14.5.2 Stada Group Oxcarbazepine Tablets Product Specification
14.5.3 Stada Group Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Apotex
14.6.1 Apotex Company Profile
14.6.2 Apotex Oxcarbazepine Tablets Product Specification
14.6.3 Apotex Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Hikma Pharmaceuticals
14.7.1 Hikma Pharmaceuticals Company Profile
14.7.2 Hikma Pharmaceuticals Oxcarbazepine Tablets Product Specification
14.7.3 Hikma Pharmaceuticals Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Taro Pharmaceuticals
14.8.1 Taro Pharmaceuticals Company Profile
14.8.2 Taro Pharmaceuticals Oxcarbazepine Tablets Product Specification
14.8.3 Taro Pharmaceuticals Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Jubilant Generics
14.9.1 Jubilant Generics Company Profile
14.9.2 Jubilant Generics Oxcarbazepine Tablets Product Specification
14.9.3 Jubilant Generics Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Teva Pharmaceutical
14.10.1 Teva Pharmaceutical Company Profile
14.10.2 Teva Pharmaceutical Oxcarbazepine Tablets Product Specification
14.10.3 Teva Pharmaceutical Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Jamp Pharma
14.11.1 Jamp Pharma Company Profile
14.11.2 Jamp Pharma Oxcarbazepine Tablets Product Specification
14.11.3 Jamp Pharma Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 SihuanPharm
14.12.1 SihuanPharm Company Profile
14.12.2 SihuanPharm Oxcarbazepine Tablets Product Specification
14.12.3 SihuanPharm Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 ANI Pharmaceuticals
14.13.1 ANI Pharmaceuticals Company Profile
14.13.2 ANI Pharmaceuticals Oxcarbazepine Tablets Product Specification
14.13.3 ANI Pharmaceuticals Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Huikang Pharmaceutical
14.14.1 Huikang Pharmaceutical Company Profile
14.14.2 Huikang Pharmaceutical Oxcarbazepine Tablets Product Specification
14.14.3 Huikang Pharmaceutical Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Neuraxpharm
14.15.1 Neuraxpharm Company Profile
14.15.2 Neuraxpharm Oxcarbazepine Tablets Product Specification
14.15.3 Neuraxpharm Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Nobelpharma
14.16.1 Nobelpharma Company Profile
14.16.2 Nobelpharma Oxcarbazepine Tablets Product Specification
14.16.3 Nobelpharma Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Glenmark Pharmaceuticals
14.17.1 Glenmark Pharmaceuticals Company Profile
14.17.2 Glenmark Pharmaceuticals Oxcarbazepine Tablets Product Specification
14.17.3 Glenmark Pharmaceuticals Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Humanwell Healthcare
14.18.1 Humanwell Healthcare Company Profile
14.18.2 Humanwell Healthcare Oxcarbazepine Tablets Product Specification
14.18.3 Humanwell Healthcare Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Orion Corporation
14.19.1 Orion Corporation Company Profile
14.19.2 Orion Corporation Oxcarbazepine Tablets Product Specification
14.19.3 Orion Corporation Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Roxane Laboratories
14.20.1 Roxane Laboratories Company Profile
14.20.2 Roxane Laboratories Oxcarbazepine Tablets Product Specification
14.20.3 Roxane Laboratories Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.21 Nexgen pharma
14.21.1 Nexgen pharma Company Profile
14.21.2 Nexgen pharma Oxcarbazepine Tablets Product Specification
14.21.3 Nexgen pharma Oxcarbazepine Tablets Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Oxcarbazepine Tablets Market Forecast (2022-2027)
15.1 Global Oxcarbazepine Tablets Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Oxcarbazepine Tablets Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Oxcarbazepine Tablets Value and Growth Rate Forecast (2022-2027)
15.2 Global Oxcarbazepine Tablets Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Oxcarbazepine Tablets Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Oxcarbazepine Tablets Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Oxcarbazepine Tablets Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Oxcarbazepine Tablets Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Oxcarbazepine Tablets Consumption Forecast by Type (2022-2027)
15.3.2 Global Oxcarbazepine Tablets Revenue Forecast by Type (2022-2027)
15.3.3 Global Oxcarbazepine Tablets Price Forecast by Type (2022-2027)
15.4 Global Oxcarbazepine Tablets Consumption Volume Forecast by Application (2022-2027)
15.5 Oxcarbazepine Tablets Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Oct 2024 |
| Category : Services |
Pages : 129 |
| Price : US$ 3500 |
Date : Oct 2024 |
| Category : Services |
Pages : 120 |
| Price : US$ 3500 |
Date : Oct 2024 |
| Category : Services |
Pages : 121 |
Request Sample 
Request Discount 
Inquire Before Buy
